Key Takeaways & Executive Findings
- •• miR-10a-5p is significantly upregulated in retinoic acid-induced neural tube defects (NTDs), leading to reduced neural stem cell proliferation and differentiation. • Chl1 is identified as a direct target of miR-10a-5p, and its downregulation mimics the effects of miR-10a-5p overexpression on NSC behavior. • The miR-10a-5p/Chl1 axis inhibits the ERK1/2 MAPK signaling pathway, which is crucial for NSC growth and differentiation. • Restoring Chl1 expression or activating ERK with honokiol reverses the inhibitory effects, highlighting potential therapeutic targets for NTDs.
Abstract
Neural tube defects (NTDs) are characterized by the failure of neural tube closure during embryogenesis and are considered the most common and severe central nervous system anomalies during early development. Recent microRNA (miRNA) expression profiling studies have revealed that the dysregulation of several miRNAs plays an important role in retinoic acid (RA)-induced NTDs. However, the molecular functions of these miRNAs in NTDs remain largely unidentified. Here, we show that miR-10a-5p is significantly upregulated in RA-induced NTDs and results in reduced cell growth due to cell cycle arrest and dysregulation of cell differentiation. Moreover, the cell adhesion molecule L1-like (Chl1) is identified as a direct target of miR-10a-5p in neural stem cells (NSCs) in vitro, and its expression is reduced in RA-induced NTDs. siRNA-mediated knockdown of intracellular Chl1 affects cell proliferation and differentiation similar to those of miR-10a-5p overexpression, which further leads to the inhibition of the expressions of downstream ERK1/2 MAPK signaling pathway proteins. These cellular responses are abrogated by either increased expression of the direct target of miR-10a-5p (Chl1) or an ERK agonist such as honokiol. Overall, our study demonstrates that miR-10a-5p plays a major role in the process of NSC growth and differentiation by directly targeting Chl1, which in turn induces the downregulation of the ERK1/2 cascade, suggesting that miR-10a-5p and Chl1 are critical for NTD formation in the development of embryos.
1. Introduction
Neural tube defects (NTDs), including spina bifida, anencephaly, myelomeningocele and encephalocele, are severe congenital anomalies caused by incomplete or defective neural tube closure during embryonic development [1–3]. NTDs are considered the second most common category of birth defects [4], affecting approximately one in every 1000 established pregnancies with a prevalence rate of 0.2–10 per 1000 in different areas [5]. The causes of NTDs appear to be complex and involve multiple genetic and environmental factors [6–8]. To date, few genes have been identified as the major contributors to NTD susceptibility, along with several known environmental risk factors, such as maternal diabetes, valproic acid, folic acid and retinoic acid (RA) [9].
RA is a vitamin A-derived metabolite that is involved in embryonic development, especially in the development of the central nervous system [10], including the migration of nerve fold cells, the closure of neural tubes, and the formation of the anterior, middle and posterior brain [11]. Excessive RA level in pregnant mammals can lead to abnormalities in brain development, including NTDs [12]. At present, excessive RA-induced animal models have been widely used to study the pathogenesis of NTDs [13,14].
Loading authentic research manuscript (Pages 1–5)...
Juan Zhang, Lihong Yang, Yuqing Sun, Li Zhang, Yufei Wang, Ming Liu, Xiujuan Li, Yuxiang Liang, Hong Zhao, Zhizhen Liu, Zhiyong Qiu, Ting Zhang, Jun Xie (2026). Up-regulation of miR-10a-5p expression inhibits the proliferation and differentiation of neural stem cells by targeting Chl1. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024078
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the role of miR-10a-5p in neural tube defects?
miR-10a-5p is significantly upregulated in retinoic acid-induced neural tube defects and inhibits neural stem cell proliferation and differentiation by targeting Chl1, leading to downregulation of the ERK1/2 MAPK signaling pathway.
How does miR-10a-5p affect neural stem cells?
Overexpression of miR-10a-5p reduces cell growth by causing cell cycle arrest and dysregulation of differentiation in neural stem cells, similar to the effects of Chl1 knockdown.
What is the direct target of miR-10a-5p in this study?
The cell adhesion molecule L1-like (Chl1) is identified as a direct target of miR-10a-5p in neural stem cells.
Can the effects of miR-10a-5p be reversed?
Yes, the effects can be abrogated by increasing Chl1 expression or by using an ERK agonist such as honokiol, which restores the ERK1/2 signaling pathway.
What is the significance of this study for NTD treatment?
The study suggests that miR-10a-5p and Chl1 are critical for NTD formation, and targeting this pathway may provide potential therapeutic strategies for preventing or treating neural tube defects.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.